MedTech Terms
    The authoritative reference
    All terms

    Data Governance (AI/ML)

    Policies, controls, and documentation for the data used to train, tune, and validate medical AI models.

    Reviewed by Christian Espinosa, Founder, Blue Goat CyberLast reviewed May 5, 2026

    Definition

    Covers data provenance, consent, de-identification, demographic representativeness, labeling quality, version control, and audit trails. EU AI Act Article 10 codifies many of these as legal requirements for high-risk systems.
    What the regulation says
    Regulators emphasize robust data governance for AI/ML in MedTech to ensure data quality, integrity, and traceability throughout the entire lifecycle. The EU AI Act (Article 10) specifically mandates requirements for data governance systems, including data quality management for training, validation, and testing datasets, for high-risk AI systems. The FDA also provides guidance on the importance of data management practices for AI/ML-based medical devices, highlighting aspects like data provenance and representativeness.

    What this means in practice

    Weak training-data governance is the most common reason medical AI submissions stall; reviewers want to see lineage as clearly as a DHF traces design.

    Examples

    • A medical device company implements a data governance framework that includes automated tracking of all data inputs, preprocessing steps, and feature engineering for its AI-powered diagnostic algorithm, providing a clear audit trail for FDA submission.
    • Before deploying an AI model for cardiac analysis, a manufacturer performs a thorough demographic analysis of its training dataset to ensure it includes sufficient representation from various age groups, genders, and ethnic backgrounds, addressing potential biases.
    • During the development of an AI-driven imaging system, the development team meticulously documents the process of de-identifying patient data to comply with HIPAA regulations, ensuring patient privacy while enabling model training.
    Common pitfalls
    • •Failing to document the complete lineage of training data, from raw acquisition to final processing, can lead to submission delays or rejections.
    • •Using biased or unrepresentative datasets without mitigation strategies can result in AI models that perform poorly or inequitably across different patient populations, raising ethical and regulatory concerns.
    • •Inadequate data labeling processes can introduce errors that propagate through the AI model, compromising its accuracy and reliability.
    • •Neglecting to implement robust version control for datasets makes it difficult to reproduce model training or trace changes, hindering regulatory compliance.
    • •Overlooking cybersecurity measures for data used in AI/ML development and deployment can expose sensitive patient information to breaches, violating privacy regulations like GDPR and HIPAA.

    Frequently asked questions

    Data provenance refers to the complete record of data's origin and all transformations it has undergone. For AI/ML, this includes tracking where data was collected, how it was processed, and any annotations or augmentations applied, essential for regulatory audits and model reproducibility.
    Grouped by theme

    Primary references

    3 sources
    Link health: 3 verified· last checked 2026-06-20
    European Parliament·1FDA·1IMDRF·1
    1. 1
      EU AI Act Article 10
      Verified
      European Parliamentartificialintelligenceact.eu
    2. 2
      FDA - AI/ML-Enabled Medical Devices
      Verified
      FDAfda.gov
    3. 3
      IMDRF - Software as a Medical Device
      Verified
      IMDRFimdrf.org

    Inline markers like [1] jump to the matching reference above.